Based on the Fragments Per Kilobase of transcript, per Million mapped reads (FPKM) value of each gene, ccRCC patients were classified into two expression groups, high and low expression (a FPKM of 5.37 and 4.66 were used as cut off for SETD2 and ATG12 expression, respectively) and the correlation between expression level and patient survival was examined. The gene discussed is SETD2; the disease is nonpapillary renal cell carcinoma.